Four things to know:
1. Allscripts expects to grow its provider space, which comprises EHRs in both the acute and ambulatory settings, 2.5 percent to 3 percent by 2022.
2. The company’s payer and life sciences division Veradigm is projected to increase at a compound annual growth rate of 15 percent to 25 percent over the next three years. Based on that estimation, Allscripts aims secure a 3.5 percent to 6 percent non-GAAP growth rate.
3. Allscripts plans to increase its merger and acquisition revenues by 2 percent to 3 percent over the next three years.
4. Collectively, the company anticipates growing its revenues at a 5.5 percent to 9 percent CAGR by 2022.
More articles on EHRs:
Nearly 1 in 3 eye care patients’ EHR may pose medication discrepancy, study finds
Physician viewpoint: Surgeons ‘shielded’ from certain paperwork, administrative tasks that cause burnout
HIMSS’ EHR association raises concerns about ONC’s proposed interoperability rule
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
